Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: Post hoc analysis of a multicentre, randomized and controlled trial

Nephrology Dialysis Transplantation

Volumn 29, Issue 6, 2014, Pages 1239-1246

  Locatelli, Francesco ^a   Altieri, Paolo ^b   Andrulli, Simeone ^a   Sau, Giovanna ^b   Bolasco, Piergiorgio ^c   Pedrini, Luciano A ^d   Basile, Carlo ^e   David, Salvatore ^f   Gazzanelli, Luanna ^g   Tampieri, Guido ^h   Isola, Elisabetta ^h   Marzolla, Onofrio ⁱ   Memoli, Bruno ^j   Ganadu, Marino ^k   Reina, Ernesto ^l   Bertoli, Silvio ^m   Ferrara, Rocco ⁿ   Casu, Domenica ^o   Logias, Francesco ^p   Tarchini, Renzo ^q   Mattana, Giovanni ^r   Passaghe, Mario ^s   Fundoni, Gianfranco ^t   Villa, Giuseppe ^u   Di Iorio, Biagio Raffaele ^v   Pontoriero, Giuseppe ^a   Zoccali, Carmine ^w   more..

^a A MANZONI HOSPITAL   (Italy)

^b BROTZU HOSPITAL   (Italy)

^c Territorial Department of Nephrology and Dialysis   (Italy)

^d BOLOGNINI HOSPITAL   (Italy)

^e MIULLI GENERAL HOSPITAL   (Italy)

^f MAGGIORE HOSPITAL   (Italy)

^g Department of Nephrology and Dialysis Centro Dialisi della Maddalena   (Italy)

^h Ospedale di Ravenna   (Italy)

ⁱ Department of Nephrology and Dialysis Centro Dialisi di Melito e Scilla   (Italy)

^j UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^k Department of Nephrology and Dialysis Centro Dialisi di Ozieri   (Italy)

^l Ospedale di Pinerolo   (Italy)

^m IRCCS MULTIMEDICA   (Italy)

ⁿ SS Trinit Hospital   (Italy)

^o Civil Hospital   (Italy)

^p IRCCS SAN CAMILLO HOSPITAL   (Italy)

^q CARLO POMA HOSPITAL   (Italy)

^r SAN FRANCESCO HOSPITAL   (Italy)

^s Department of Nephrology and Dialysis   (Italy)

^t San Giovanni di Dio Hospital   (Italy)

^u IRCCS   (Italy)

^v Ospedale Agostino Landolfi   (Italy)

^w BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

more..

Author keywords

convective therapies; haemodialysis; on line haemodiafiltration; on line haemofiltration; phosphate

Indexed keywords

ALUMINUM DERIVATIVE; BICARBONATE; CALCIUM; CALCIUM DERIVATIVE; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; POTASSIUM; SEVELAMER; VITAMIN D;

ADULT; AGED; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CONTROLLED STUDY; DRUG USE; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMODYNAMIC PARAMETERS; HEMOFILTRATION; HUMAN; INTERMETHOD COMPARISON; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONLINE ANALYSIS; OPEN STUDY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; POST HOC ANALYSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT;

CONVECTIVE THERAPIES; HAEMODIALYSIS; ON-LINE HAEMODIAFILTRATION; ON-LINE HAEMOFILTRATION; PHOSPHATE;

AGED; BICARBONATES; CALCIUM; FEMALE; HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY;

EID: 84901776080     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu031     Document Type: Article

References (28)

1. Gutierrez O, Isakova T, Rhee E et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2205-2215 (Pubitemid 41716454)
2. Palmer SC, Hayen A, Macaskill P et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 2011; 305: 1119-1127
3. KDIGO Guidelines on MBD disorders in CKD. Treatment of CKD-MBD targeted at lowering high serum phosphorus and maintaining serum calcium. Kidney Int 2009; 76 (Suppl 113): S50-S99
4. Tonelli M, Wang W, Hemmelgarn B et al. Alberta Kidney Disease Network: phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients. Am J Kidney Dis 2009; 54: 1108-1115
5. Gallar P, Ortiz M, Ortega O et al. Factors which influence phosphorus removal in hemodialysis. Nefrologia 2007; 27: 46-52
6. Gutzwiller JP, Schneiditz D, Huber AR et al. Increasing blood flow increases kt/V(urea) and potassium removal but fails to improve phosphate removal. Clinic Nephrol 2003; 59: 130-136 (Pubitemid 36221748)
7. Pieratos A, Owendyk M, Francoeur R et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998; 9: 859-868 (Pubitemid 28209096)
8. Zehnder C, Gutzwiller JP, Renggli K. Hemodiafiltration: a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 1999; 52: 152-159 (Pubitemid 29419469)
9. Albalate C, Fernandez MD, Lopez C et al. Can we increase phosphate removal with conventional hemodialysis? Nefrologia 2003; 23: 520-527
10. Davenport A, Gardner C, Delaney M; Pan Thames Renal Audit Group. The effect of dialysis modality on phosphate control: haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit. Nephrol Dial Transplant 2010; 25: 897-901
11. Locatelli F, Altieri P, Andrulli S et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol 2010; 21: 1798-1807
12. Bolasco P, Altieri P, Andrulli S et al. Convection versus diffusion in dialysis: an Italian prospective multicentre study. Nephrol Dial Transplant 2003; 18 (Suppl 7): 50-54
13. Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V and ePCRn. AdvRen Replace Ther 1995; 2: 295-304
14. Winkelmayer WC, Liu J, Kestenbaum B: Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients. Clin J Am Soc Nephrol 2011; 6: 175-183
15. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 2009; 76 (Suppl 113): S1-S130
16. Al-Hejaili F, Kortas C, Leitch R et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003; 14: 2322-2328 (Pubitemid 37052379)
17. Gutzwiller JP, Schneditz D, Huber AR et al. Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose. Nephrol Dial Transplant 2002; 17: 1037-1044 (Pubitemid 34746206)
18. Pedrini LA, De Cristofaro V, Comelli M et al. Long-term effects of high-efficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study. Nephrol Dial Transplant 2011; 26: 2617-2624
19. Movilli E, Camerini C, Gaggia P et al. Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. Nephrol Dial Transplant 2011; 26: 4032-4037
20. LornoyW, De Meester J, Becaus I et al. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients. J Ren Nutr 2006; 16: 47-53 (Pubitemid 43088755)
21. Penne EL, van der Weerd NC, van den Dorpel MA et al. Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST). Am J Kidney Dis 2010; 55: 77-87
22. Ok E, Asci G, Toz H et al. Turkish Online Haemodiafiltration Study: mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 2013; 28: 192-202
23. Maduell F, Moreso F, Pons M et al. ESHOL Study Group: high-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 2013; 24: 487-497
24. Spalding EM, Chamney PW, Farrington K. Phosphate kinetics during hemodialysis: evidence for biphasic regulation. Kidney Int 2002; 61: 655-667 (Pubitemid 34102609)
25. WalshM, Manns BJ, Klarenbach S et al. The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: a randomizedcontrolled trial. Hemodial Int 2010; 14: 174-181
26. Manley HJ, Garvin CG, Drayer DK et al. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant 2004; 19: 1842-1848 (Pubitemid 38961397)
27. Cannata-Andía JB, Fernández-Martín JL, Locatelli F et al. Use of phosphate- binding agents is associated with a lower risk of mortality. Kidney Int 2013; 84: 998-1008
28. Jamal SA, Vandermeer B, Raggi P et al. Effect of calcium-based versus noncalcium- based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 2013; 382: 1268-1277